Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.12 USD | -2.39% |
|
+1.45% | -3.10% |
06-05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
06-05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.10% | 3.66B | |
+2.97% | 94.74B | |
-4.08% | 37.28B | |
-13.26% | 32.68B | |
+73.45% | 27.72B | |
-11.58% | 16.19B | |
-1.66% | 13.88B | |
-11.67% | 11.58B | |
+190.36% | 10.92B | |
-52.61% | 9.54B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories